Marzia Del Re

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 32

Top Venues

Cancers

JCO precision oncology

Cancer

The pharmacogenomics journal

Universita' di Pisa

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universita' di Pisa May 01 2016 - Jan 01 2017

Italy

Assegnisti :: DIP. DI MEDICINA CLINICA E SPERIMENTALE - disattivato

Universita' di Pisa May 01 2016 - Jan 01 2017

Italy

Assegnisti :: DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE

Università di Pisa May 01 2016 - Jan 01 2017

Italy

Assegnisti :: DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE

Universita' di Pisa Mar 01 2014 - May 30 2014

Italy

Collaboratori :: DIPARTIMENTO DI FARMACIA

Università di Pisa Mar 01 2014 - May 30 2014

Italy

Collaboratori :: DIPARTIMENTO DI FARMACIA

Publications

Christian D Rolfo, Marzia Del Re, Alessandro Russo
Exploring the epigenetic susceptibility mechanisms of lung cancer through DNA methylation markers. Cancer 130 (6) (2024)
Alessandro Russo, Jessica K Lee, Lincoln W Pasquina, Marzia Del Re, Holli H Dilks, Karthikeyan Murugesan, Russell W Madison, Yi Lee, Alexa B Schrock, Leah A Comment, Martin Dietrich, Geoffrey R Oxnard, Christian D Rolfo
Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment. JCO precision oncology 8 (2024)
Alessandro Russo, Jessica K Lee, Lincoln W Pasquina, Marzia Del Re, Holli H Dilks, Karthikeyan Murugesan, Russell W Madison, Yi Lee, Alexa B Schrock, Leah A Comment, Martin Dietrich, Geoffrey R Oxnard, Christian D Rolfo
Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment. JCO precision oncology 8 (2024)
Christian D Rolfo, Marzia Del Re, Alessandro Russo
Exploring the epigenetic susceptibility mechanisms of lung cancer through DNA methylation markers. Cancer (2024)
Alessandro Russo, Jessica K Lee, Lincoln W Pasquina, Marzia Del Re, Holli H Dilks, Karthikeyan Murugesan, Russell W Madison, Yi Lee, Alexa B Schrock, Leah A Comment, Martin Dietrich, Geoffrey R Oxnard, Christian D Rolfo
Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment. JCO precision oncology 8 (2024)
Rosa Teresa Scaramuzzo, Stefania Crucitta, Marzia Del Re, Maurizio Cammalleri, Paola Bagnoli, Massimo Dal Monte, Alessandro Pini, Luca Filippi
β3-adREnoceptor Analysis in CORD Blood of Neonates (β3 RECORD): Study Protocol of a Pilot Clinical Investigation. Life (Basel, Switzerland) 14 (6) (2024)
Rosa Teresa Scaramuzzo, Stefania Crucitta, Marzia Del Re, Maurizio Cammalleri, Paola Bagnoli, Massimo Dal Monte, Alessandro Pini, Luca Filippi
β3-adREnoceptor Analysis in CORD Blood of Neonates (β3 RECORD): Study Protocol of a Pilot Clinical Investigation. Life (Basel, Switzerland) 14 (6) (2024)
Christian D Rolfo, Marzia Del Re, Alessandro Russo
Exploring the epigenetic susceptibility mechanisms of lung cancer through DNA methylation markers. Cancer 130 (6) (2024)
Christian D Rolfo, Marzia Del Re, Alessandro Russo
Exploring the epigenetic susceptibility mechanisms of lung cancer through DNA methylation markers. Cancer 130 (6) (2024)
Stefania Crucitta, Martina Ruglioni, Giulia Lorenzini, Irene Bargagna, Giovanna Irene Luculli, Irene Albanese, Diana Bilancio, Francesca Patanè, Andrea Fontana, Romano Danesi, Marzia Del Re
CDK4/6 Inhibitors Overcome Endocrine ESR1 Mutation-Related Resistance in Metastatic Breast Cancer Patients. Cancers 15 (4) (2023)
Christian D Rolfo, Marzia Del Re, Alessandro Russo
Empower the potential of trastuzumab deruxtecan with novel combinations. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Stefania Crucitta, Martina Ruglioni, Giulia Lorenzini, Irene Bargagna, Giovanna Irene Luculli, Irene Albanese, Diana Bilancio, Francesca Patanè, Andrea Fontana, Romano Danesi, Marzia Del Re
CDK4/6 Inhibitors Overcome Endocrine ESR1 Mutation-Related Resistance in Metastatic Breast Cancer Patients. Cancers 15 (4) (2023)
Stefania Crucitta, Martina Ruglioni, Giulia Lorenzini, Irene Bargagna, Giovanna Irene Luculli, Irene Albanese, Diana Bilancio, Francesca Patanè, Andrea Fontana, Romano Danesi, Marzia Del Re
CDK4/6 Inhibitors Overcome Endocrine ESR1 Mutation-Related Resistance in Metastatic Breast Cancer Patients. Cancers 15 (4) (2023)
Federico Cucchiara, Rosa Scarpitta, Stefania Crucitta, Cristian Scatena, Roberta Arici, Antonio Giuseppe Naccarato, Stefano Fogli, Romano Danesi, Marzia Del Re
Diagnosis and treatment monitoring in breast cancer: how liquid biopsy can support patient management. Pharmacogenomics 23 (2) (2022)
Francesco Pantano, Francesca Zalfa, Michele Iuliani, Sonia Simonetti, Francesco Pantano, Andrea Napolitano, Simone Tiberi, Marco Russano, Fabrizio Citarella, Simone Foderaro, Elisabetta Vulpis, Alessandra Zingoni, Laura Masuelli, Roberto Bei, Giulia Ribelli, Marzia Del Re, Romano Danesi, Bruno Vincenzi, Giuseppe Perrone, Giuseppe Tonini, Daniele Santini
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients. Cancers 14 (10) (2022)
Margherita Ambrosini, Marzia Del Re, Francesco Pantano, Andrew E Hendifar, Alexander E Drilon, Guilherme Harada, Anne Hansen Ree, Samuel J Klempner, Gunhild Mari Mælandsmo, Norman John Carr, Hege G Russnes, James M Cleary, Harshabad Singh, Elisa Sottotetti, Antonia Martinetti, Giovanni Randon, Andrea Sartore-Bianchi, Iolanda Capone, Massimo Milione, Maria Di Bartolomeo, Filippo Pietrantonio
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series. JCO precision oncology 6 (2022)
Federica Marmorino, Michele Prisciandaro, Mirella Giordano, Elisa Ortolan, Stefania Crucitta, Francesco Pantano, Carlotta Antoniotti, Marta Maria Valenti, Romano Danesi, Veronica Conca, Giacomo Mazzoli, Alessandra Boccaccino, Martina Carullo, Antonia Martinetti, Elisa Sottotetti, Gianluca Masi, Carlo Sposito, Nadia Zaffaroni, Massimo Milione, Gabriella Fontanini, Marzia Del Re, Filippo Pietrantonio, Chiara Cremolini
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases. JCO precision oncology 6 (2022)
Sara Galimberti, Serena Balducci, Francesca Guerrini, Marzia Del Re, Rossella Cacciola
Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular Tool. Diagnostics (Basel, Switzerland) 12 (6) (2022)
Agata Janowska, Michela Iannone, Cristian Fidanzi, Marco Romanelli, Luca Filippi, Marzia Del Re, Manuella Martins, Valentina Dini
The Genetic Basis of Dormancy and Awakening in Cutaneous Metastatic Melanoma. Cancers 14 (9) (2022)
Gabriele Moretti, Paolo Aretini, Francesca Lessi, Chiara Maria Mazzanti, Guntulu Ak, Muzaffer Metintaş, Cecilia Lando, Rosa Angela Filiberti, Marco Lucchi, Alessandra Bonotti, Rudy Foddis, Alfonso Cristaudo, Andrea Bottari, Alessandro Apollo, Marzia Del Re, Romano Danesi, Luciano Mutti, Federica Gemignani, Stefano Landi
Liquid Biopsies from Pleural Effusions and Plasma from Patients with Malignant Pleural Mesothelioma: A Feasibility Study. Cancers 13 (10) (2021)
Marzia Del Re, Caterina Vivaldi, Eleonora Rofi, Francesca Salani, Stefania Crucitta, Silvia Catanese, Lorenzo Fontanelli, Valentina Massa, Federico Cucchiara, Lorenzo Fornaro, Annalisa Capuano, Stefano Fogli, Enrico Vasile, Romano Danesi
Gemcitabine Plus Nab-Paclitaxel Induces PD-L1 mRNA Expression in Plasma-Derived Microvesicles in Pancreatic Cancer. Cancers 13 (15) (2021)
Elena S Martens-Uzunova, Gina D Kusuma, Stefania Crucitta, Hong Kiat Lim, Crystal Cooper, James E Riches, Arun Azad, Takahiro Ochiya, Glen M Boyle, Melissa C Southey, Marzia Del Re, Rebecca Lim, Grant A Ramm, Guido W Jenster, Carolina Soekmadji
Androgens alter the heterogeneity of small extracellular vesicles and the small RNA cargo in prostate cancer. Journal of extracellular vesicles 10 (10) (2021)
Letizia Procaccio, Francesca Bergamo, Francesca Daniel, Cosimo Rasola, Giada Munari, Paola Biason, Stefania Crucitta, Giulia Barsotti, Giulia Zanella, Valentina Angerilli, Cristina Magro, Silvia Paccagnella, Veronica Di Antonio, Fotios Loupakis, Romano Danesi, Vittorina Zagonel, Marzia Del Re, Sara Lonardi, Matteo Fassan
A Real-World Application of Liquid Biopsy in Metastatic Colorectal Cancer: The Poseidon Study. Cancers 13 (20) (2021)
Tessa A M Mulder, Mirjam de With, Marzia Del Re, Romano Danesi, Ron H J Mathijssen, Ron H N van Schaik
Clinical CYP2D6 Genotyping to Personalize Adjuvant Tamoxifen Treatment in ER-Positive Breast Cancer Patients: Current Status of a Controversy. Cancers 13 (4) (2021)
Caterina Vivaldi, Stefania Crucitta, Silvia Catanese, Federico Cucchiara, Elena Arrigoni, Irene Pecora, Eleonora Rofi, Lorenzo Fornaro, Francesca Salani, Valentina Massa, Enrico Vasile, Riccardo Morganti, Romano Danesi, Marzia Del Re
Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel. The pharmacogenomics journal 21 (2) (2021)
Francesco Passiglia, Michela Cinquini, Lorenzo Spaggiari, Marzia Del Re, Francesco Facchinetti, Roberto Ferrara, Tindara Franchina, Anna Rita Larici, Umberto Malapelle, Jessica Menis, Antonio Passaro, Sara Pilotto, Sara Ramella, Giulio Rossi, Rocco Trisolini, Silvia Novello
Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (23) (2021)
Marzia Del Re, Federico Cucchiara, Iacopo Petrini, Stefano Fogli, Antonio Passaro, Stefania Crucitta, Ilaria Attili, Filippo De Marinis, Antonio Chella, Romano Danesi
erbB in NSCLC as a molecular target: current evidences and future directions. ESMO open 5 (4) (2021)
Stefania Crucitta, Marzia Del Re, Federico Paolieri, Francesco Bloise, Andrea Sbrana, Enrico Sammarco, Chiara Mercinelli, Federico Cucchiara, Lorenzo Fontanelli, Luca Galli, Romano Danesi
CYP17A1 polymorphism c.-362T>C predicts clinical outcome in metastatic castration-resistance prostate cancer patients treated with abiraterone. Cancer chemotherapy and pharmacology 86 (4) (2020)
Marzia Del Re, Giulia Gianfilippo, Stefania Crucitta, Alfredo Addeo, Ron Hn van Schaik, Romano Danesi
Circulating biomarkers of response to immunotherapy in cancer treatment. Pharmacogenomics 20 (18) (2019)
Stefania Crucitta, Giuliana Restante, Marzia Del Re, Ilaria Bertolini, Eleonora Bona, Eleonora Rofi, Lorenzo Fontanelli, Giulia Gianfilippo, Stefano Fogli, Irene Stasi, Matteo Ghilli, Andrea Fontana, Romano Danesi
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy. Cancer chemotherapy and pharmacology 84 (6) (2019)
Marzia Del Re, Stefania Crucitta, Giulia Gianfilippo, Antonio Passaro, Iacopo Petrini, Giuliana Restante, Angela Michelucci, Stefano Fogli, Filippo de Marinis, Camillo Porta, Antonio Chella, Romano Danesi
Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy. International journal of molecular sciences 20 (16) (2019)
Marzia Del Re, Saverio Cinieri, Angela Michelucci, Stefano Salvadori, Fotios Loupakis, Marta Schirripa, Chiara Cremolini, Stefania Crucitta, Cecilia Barbara, Angelo Di Leo, Tiziana Pia Latiano, Filippo Pietrantonio, Samantha Di Donato, Paolo Simi, Alessandro Passardi, Filippo De Braud, Giuseppe Altavilla, Claudio Zamagni, Roberto Bordonaro, Alfredo Butera, Evaristo Maiello, Carmine Pinto, Alfredo Falcone, Valentina Mazzotti, Riccardo Morganti, Romano Danesi
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients. The pharmacogenomics journal 19 (6) (2019)

Marzia Del Re.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marzia Del Re